Philips Launches eV14-2v Transducer for Women’s Health
Amsterdam, the Netherlands, September 3, 2026 Royal Philips has introduced the eV14-2v transvaginal transducer, a new single-transducer solution designed...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Amsterdam, the Netherlands, September 3, 2026 Royal Philips has introduced the eV14-2v transvaginal transducer, a new single-transducer solution designed...
PHILADELPHIA, July 31, 2026 Medicus Pharma Ltd. announced that the United Arab Emirates (UAE) Department of Health – Abu...
CAMBRIDGE, UK, May 19, 2026 Cyclana Bio announced that it has received Health Research Authority (HRA) and Research Ethics...
